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Abstract
There is an increasing interest in curcumin (Curcuma longa L.) as a cardiovascular disease (CVD) protective agent via decreased blood total 
cholesterol and low-density lipoprotein-cholesterol (LDL-cholesterol) level. The aim of this study was to investigate further the potential mechanism
in the hypocholesterolemic effect of curcumin by measuring cholesterol 7a-hydroxylase (CYP7A1), a rate limiting enzyme in the biosynthesis of
bile acid from cholesterol, at the mRNA level. Male Sprague-Dawley rats were fed a 45% high fat diet or same diet supplemented with curcumin 
(0.1% wt/wt) for 8 weeks. The curcumin diet significantly decreased serum triglyceride (TG) by 27%, total cholesterol (TC) by 33.8%, and LDL-cholesterol
by 56%, respectively as compared to control group. The curcumin-supplemented diet also significantly lowered the atherogenic index (AI) by 48% 
as compared to control group. Hepatic TG level was significantly reduced by 41% in rats fed with curcumin-supplemented diet in comparison with
control group (P < 0.05). Conversely, the curcumin diet significantly increased fecal TG and TC. The curcumin diet up-regulated hepatic CYP7A1
mRNA level by 2.16-fold, compared to control group p (P< 0.05). These findings suggested that the increases in the CYP7A1 gene expression
may partially account for the hypocholesterolemic effect of curcumin.
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Introduction3)
Cardiovascular disease (CVD) is one of the main causes of 
mortality globally. The World Health Organization (WHO) has 
predicted an increase in prevalence of CVD, with projected 
combined death toll of 24 million by 2030 [1]. An increased 
blood cholesterol level, which is governed by cholesterol 
absorption, synthesis, storage, and excretion, is one of the major 
risk factors leading to the development of CVD [2]. The 
conversion of cholesterol to bile acids in the liver is an important 
pathway for the elimination of cholesterol from the body [3]. 
Cholesterol 7a-hydroxylase (CYP7A1) is a liver-specific enzyme 
that catalyzes the rate-limiting step in the biosynthesis of bile 
acid from cholesterol.
The need to decrease plasma lipids has been recognized and 
dietary control of blood cholesterol has been explored [4]. Plants 
and phytochemicals have been shown to exert CVD protective 
effects in epidemiological analysis, animal experiments, and 
clinical trials [4-7]. These effects could be due to plant 
polyphenolic compounds that possess an aromatic ring bearing 
one or more hydroxyl groups [8]. 
Curcuma longa L. (turmeric), which belongs to the Zingiberacae 
family [9], is a perennial plant that has been widely used as 
spice, coloring adjuncts and also as a major ingredient of curry 
powder [10]. Tumeric has a long history of use as traditional 
medicines of China and India [11], reflecting the compound’s 
diverse and beneficial health effects. Curcumin is a phenolic 
compound present in the turmeric roots. Commercially available 
turmeric powders contain 2.71-5.18g of curcumin per 100g with 
100 g curry powder typically containing 0.34-0.47g curcumin 
[12]. Several intervention studies using animal models have 
showed that curcumin has a hypocholesterolemic effect [13,14]. 
A plausible explanation for curcumin-mediated lowered con-
centration of blood cholesterol involves stimulated conversion 
of cholesterol to bile acids via increase of cholesterol 
7a-hydroxylase (CYP7A1) enzyme activity [15]. 
The conversion of cholesterol to bile acids in the liver is an 
important pathway for the elimination of cholesterol from the 
body [3]. Cholesterol 7a-hydroxylase (CYP7A1) is a liver- 
specific enzyme that catalyzes the rate-limiting step in the 
biosynthesis of bile acid from cholesterol in liver. The objective 
of this study was to elucidate the molecular details of the 
hypocholesterolemic effect of curcumin. This regulation could 
be explained by alterations of the expression of gene that is 
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involved in cholesterol homeostasis in the body. The previous 
studies mainly indicated the hypocholesterolemic role of 
curcumin at the enzyme activity level [15]. We hypothesized that 
curcumin reduces concentration of blood cholesterol via 
induction of the CYP7A1 gene expression. 
Materials and Methods
Materials 
Curcumin was obtained from Sigma-Aldrich (St Louis, MO, 
USA). All other chemicals were of the highest pure grade available.
Animals and diets 
Four-week-old male Sprague-Dawley rats (SLC, Japan) were 
randomly assigned to two groups (n = 6) after 1 week of adaption 
for metabolic stabilization. The animals were all individually 
housed in stainless steel cages in a room kept at 22 ± 1℃ with 
a 12 h -hour light/dark cycle. Experimental diets employed were 
the modified AIN93 diet (Dyets, Bethlehem, PA). All diets 
contained 45% high fat in order to induce hypercholesterolemia. 
Rats were maintained on a curcumin-free diet and a diet with 
0.1% (w/w) curcumin for 8 weeks. The body weight and energy 
intake were measured twice a week. All animal procedures 
conformed to NIH guidelines as stated in the “Principles of 
Laboratory Animal Care” [16].
Sampling procedures 
At the end of the experiment, animals were anesthetized and 
a central longitudinal incision was made into the abdominal wall. 
Blood samples were collected by cardiac puncture. Liver samples 
were excised, immediately frozen in liquid nitrogen and stored 
at -70℃. The feces were collected on week 8 for 3 days and dried.
Measurement of serum parameters
Serum concentrations of triglyceride (TG), total cholesterol 
(TC), high-density lipoprotein cholesterol (HDL-C), and activities 
of glutamic-oxaloacetic transaminase (GOT) and glutamate- 
pyruvate transaminase (GPT) were measured by an enzymatic 
colorimetric method [17] using a commercial enzymatic kit (Asan 
Pharmaceutical, Seoul, Korea). Low density lipoprotein cholesterol 
(LDL-C) was calculated as: LDL-C = TC-[(HDL-C-TG)/2] [18]. 
The atherogenic index (AI) was calculated as: AI = (TC-HDL-C)/ 
HDL-C [19]. 
Hepatic and fecal lipid analyses 
Total lipid from liver and feces was extracted as previously 
described [20]. The concentrations of TG and TC from extracted 
total lipid were measured by an enzymatic colorimetric method 
[17] using a commercial enzymatic kit (Asan Pharmaceutical, 
Seoul, Korea).
Quantitative real-time RT-PCR 
Total RNA was isolated from liver tissue using Trizol reagent 
(Invitrogen, Calsbad, USA). The cDNAs were synthesized from 
4 µg total RNA using M-MLV reverse transcriptase (Invitrogen). 
After cDNA synthesis, quantitative real-time PCR was performed 
in 25 µL QuantiTect SYBR Green PCR Kit solution (Qiagen, 
Valencia, CA, USA) using a Rotor gene 3000 (Corbett Research, 
Mortlake, Australia). The reaction mixture was incubated for an 
initial denaturation at 95℃ for 15 min, followed by 40 cycles 
of 95℃ for 15 s, 60℃ for 60 s and 72℃ for 30 s. Primers 
were designed using an on-line program (Primer3; http://frodo.wi. 
mit.edu/) [21]. Primers for rat CYP7A1 were forward: 5’-TGC 
TCT GTG TTC ACT TTC TG-3’, reverse: 5’-ACT CGG TAA 
CAG AAG GCA TA-3’ and for rat β-actin were forward: 
5’-GGC ACC ACA CTT TCT ACA AT-3’, reverse: 5’-AGG 
TCT CAA ACA TGA TCT GG-3’. The ΔCT method was used 
to measure relative quantification. The ΔCT value for each 
sample was determined by calculating the difference between the 
CT value of the target gene and the CT value of the β-actin 
reference gene. Values were expressed as fold-change over 
control and expressed as the mean ± SE (n = 6). All PCR products 
were separated by electrophoresis using 1.5% agarose gel stained 
with ethidium bromide and visualized under ultraviolet light.
Statistical analysis 
All data are expressed as mean ± SE. The statistical 
significance of difference between the control and curcumin- 
treated groups was analyzed by Student’s t-test using the SPSS 
package program version 17.0 (SPSS, Chicago, IL, USA). The 
results were considered significant at P < 0.05.
Results 
Effect of dietary curcumin on body weight and energy efficiency 
ratio 
Rats fed with the curcumin-supplemented diet for 8 weeks did 
not show difference in body weight compared to the control 
group (Fig. 1A). Also, there was no diet-related difference in 
the energy efficiency ratio (EER) between groups (Fig. 1B).
Effect of dietary curcumin on serum lipid profile and activities 
of GOT and GPT 
Rats fed the curcumin-supplemented diet showed a significantly 
decreased serum TG level by 27% in comparison with control Minji Kim and Yangha Kim 193
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Fig. 1. Effect of dietary curcumin supplementation on body weight. Rats were 
fed a 45% high-fat diet with or without curcumin (0.1% w/w) for 8 weeks. B od y 
weight (A) and food intake were measured twice per week. EER (B) was calculated 
as;  body  weight  gain  (g)/food  intake  (g).  Data  are  expressed  as m ean±S E M  (n
=6 ) .  
Table 1. Serum total cholesterol, LDL and HDL cholesterol, and triglyceride 
levels of animals fed with curcumin supplemented diet
Control Curcumin
Total Cholesterol (mg/dl) 109.4 ± 4.06 72.4 ± 4.52*
LDL Cholesterol (mg/dl) 32.4 ± 4.03 10.2 ± 3.74*
HDL Cholesterol (mg/dl) 34.3 ± 2.54 31.1 ± 1.83
Triglyceride (mg/dl) 213.7 ± 7.75 155.6 ± 10.9*
Values  were  expressed  as  mean ± SEM  (n = 6). 
* Means  significantly  different  from  control  group  at  P < 0.05.
(A)
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Fig. 2. Effect of dietary curcumin supplementation on atherpgenic index and 
serum activities of GOT and GPT. Rats  were  fed  a  45%  high-fat  diet  with  or 
without  curcumin  (0.1%  w/w)  for  8  weeks.  Data  are  expressed  as  mean ± SEM 
(n = 6).  Serum  lipids  were  measured  by  an  enzymatic  colorimetric  method.  The 
atherogenic  index  (A)  was  calculated  as:  AI = (TC-HDL-C)  /  HDL-C. T h e  s e r u m  
activities  of  glutamic-oxaloacetic  transaminase  (GOT)  and  glutamate-pyruvate 
transaminase  (GPT)  (B)  were  measured  by  an  enzymatic  colorimetric  method. 
*Means  significantly  different  from  control  group  at  P < 0.05. 
Table 2. Influence of dietary curcumin on hepatic and fecal lipid profiles 
Control Curcumin
Hepatic lipids
Triglyceride (mg/g liver) 24.8 ± 3.81 14.9 ± 2.56*
Total cholesterol (mg/g liver) 9.15 ± 0.14 8.90 ± 0.18
Fecal lipids
Triglyceride (mg/day) 4.09 ± 0.14 5.52 ± 0.23*
Total cholesterol (mg/day) 17.5 ± 0.42 20.6 ± 0.85*
Values  were  expressed  as  mean ± SEM  (n = 6). 
*Means  significantly  different  from  control  group  at  P < 0.05.
group (P < 0.05) (Table 1). The curcumin diet also significantly 
lowered serum TC and LDL-C by 34% and 68%, respectively, 
compared to the control group (P < 0.05) (Table 1). Serum 
HDL-C level was not affected by curcumin supplementation 
(Table 1). In addition, AI was significantly decreased in dietary 
curcumin supplemented rats by 48% in comparison with control 
group (P < 0.05) (Fig. 2A). The serum activities of glutamic- 
oxaloacetic transaminase (GOT) and glutamate-pyruvate transaminase 
(GPT) were within the normal range for rats, showing 67-72 IU/l 
and 16-21 IU/l, respectively (Fig. 2B). No significant diet-related 
differences were shown between groups. 194 Hypocholesterolemic effects of curcumin
Fig. 3. Effects of dietary curcumin supplementation on hepatic CYP7A1 mRNA 
expression. Rats were fed a 45% high-fat diet with or without curcumin (0.1% w/w) 
for  8  weeks.  Total  RNA  was  extracted  from  liver  and  the  CYP7A1  mRNA  was 
measured by quantitative real-time PCR. Values are expressed as the fold-change 
over control as mean ± SEM (n = 6). *Means significantly different from control group 
at  P < 0.05. 
Effect of dietary curcumin on the hepatic and fecal lipid profiles 
Hepatic TG level was significantly reduced by 40% in rats 
fed with curcumin-supplemented diet in comparison with control 
group (P < 0.05) (Table 2). There was no difference in hepatic 
TC level between groups. Fecal TG and cholesterol 
concentrations were significantly increased by 34% and 17%, 
respectively in rats fed with curcumin-supplemented diet as 
compared with the control group (P < 0.05) (Table 2).
Effect of curcumin on hepatic CYP7A1 mRNA 
Real-time RT-PCR determined that consumption of curcumin 
resulted in a significantly elevated mRNA level of hepatic 
CYP7A1 by 2.16-fold compared to the control group (P<0 . 0 5 ) 
(Fig. 3).
Discussion
The observations in human [7] and animal studies [22] showed 
an inverse association between curcumin supplementation and 
the concentrations of serum cholesterol and triglyceride. 
Administration of 500 mg curcumin to human volunteers for 1 
week did produce significant change in serum cholesterol level, 
with curcumin tending to lower serum cholesterol and TG levels 
[7]. Contrary to these results, consumption of curcumin over 1 
month or 6 months was reported not to affect blood concentrations 
of TG, or TC, LDL, and HDL-cholesterol [23]. Thus, we 
investigated the hypochlestrolemic effect of curcumin in high-fat 
diet treated rats. Furthermore, to investigate the mechanism of 
the hypochlestrolemic action of curcumin, we examined the effect 
of curcumin on the regulation of gene expression of cholesterol 
7a-hydroxylase (CYP7A1), a rate limiting enzyme in bile acid 
biosynthesis from cholesterol.
The induction of hypercholesterolemia in experimental rats or 
mice by feeding a high-cholesterol or high-fat diet has been 
widely suggested as a reliable model to study hypochlestrolemic 
effect of curcumin [14,15,22]. The 0.1% (w/w) dose of curcumin 
used in animal studies, including the present study, roughly 
corresponds to twice the calculated dietary intake of curcumin 
in a study conducted in India [24]. This is likely not a concern, 
since studies indicate that consumption of up to 12 g of curcumin 
daily is not harmful or toxic to human and animals [24]. In our 
study, a diet enriched with curcumin showed a significant 
decrease in the levels of serum TG, TC, and LDL-C as reported 
by previous studies [14,15,22]. In addition, curcumin significantly 
decreased the AI, which is an important risk index for CVD, 
clearly demonstrating hypocholesterolemic potential of curcumin. 
In this study, curcumin significantly decreased hepatic TG level 
while there was no reduction in cholesterol level. Similarly, 
another study reported that 0.2% curcumin treatment significantly 
reduced hepatic TG but not cholesterol level [25]. Our 
experiments showed that fecal TG and cholesterol levels were 
greater in rats fed with the curcumin-supplemented diet than the 
control diet, reflecting that cholesterol may bind to curcumin and 
be excreted. These results are consistent with the previous study 
reporting the curcumin-mediated increase in fecal excretion of 
cholesterol and bile acid [26]. It was suggested that curcumin 
may prevent the absorption of cholesterol and lipids by disrupting 
micelle formation and promote fecal excretion of total steroids 
and bile acids [27]. 
When excretion of bile acids increases, conversion of 
cholesterol to bile acids in the liver will be enhanced in order 
to replenish the loss in bile acids. Conversion of cholesterol to 
bile acids is the major pathway of cholesterol elimination and 
accounts for about 50% of daily cholesterol excretion [28]. 
Curcumin was reported to decrease the serum cholesterol via 
enhanced CYP7A1 enzyme activity, which controls cholesterol 
homeostasis [15]. In our study, rats consuming the curcumin diet 
showed a significant increase in hepatic CYP7A1 mRNA level. 
Curcumin treatment was reported to up-regulate the LDL- 
receptor mRNA in human hepatoma HepG2 cells [29] suggesting 
that curcumin regulates expression of genes involved in 
cholesterol homeostasis. Overall, the increase in hepatic CYP7A1 
gene expression may be a mechanism that partially accounts for 
the hypocholesterolemic effect of curcumin. Curcumin stimulated 
the activation and expression of AMP-activated protein kinase 
and peroxisome proliferator-activated receptor involved in 
adipocyte energy metabolism in subcutaneous adipose tissue of Minji Kim and Yangha Kim 195
mice fed a curcumin-supplemented high fat diet [22]. It would 
be of interest to further investigate the signal pathway related 
CYP7A1 gene expression that curcumin might involve. In 
conclusion, curcumin significantly decreased serum total- and 
LDL-cholesterol level and triglyceride level. Also, curcumin 
enhanced hepatic CYP7A1 gene expression. These results 
suggested that increased CYP7A1 gene expression may partially 
account for the role in the cholesterol lowering effect of 
curcumin.
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